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ABSTRACT 
Background: - Malaria is leading public health problem in the world especially in sub-
Saharan African countries including Ethiopia. Early and accurate diagnosis followed by 
prompt and effective treatment is main strategy for prevention and control of malaria. Despite 
to this, current diagnostic methods such as Giemsa microscopy and rapid diagnostic tests 
could not produce reliable results. Hence, highly sensitive, specific and rapid molecular 
method of diagnosis is urgently needed. 
 Objective: - To compare the performance of LAMP with Giemsa microscopy for the 
diagnosis of malaria at Kola Diba Health Center, Northwest Ethiopia from March 2014 to 
May 2014. 
Methods: A cross sectional study was conducted to evaluate LAMP performance with 
Giemsa microscopy in diagnosing malaria. Blood samples were collected from 200 
consequently recruited malaria suspected study participants and examined for Plasmodium 
parasites using Giemsa microscopy. Fifty two malaria slide negative and thirty malaria slide 
positive individuals were included in LAMP evaluation study. Data was analyzed by SPSS 
version 20 and MedCalc online software. Primary outcome measures for diagnostic accuracy 
(sensitivity, specificity, and predictive value and Kappa value) of LAMP were computed and 
compared with Giemsa microscopy. 
Results: - Among 82 samples analyzed for LAMP assay, 38 samples were tested positive for 
genus plasmodium parasite and 26 were tested positive for P. falciparum parasite. Using 
Giemsa microscopy as reference method the sensitivity, specificity, positive and negative 
predictive values of LAMP assay were 100%, and 84.62%, 78.95% and 100%, respectively, 
for the Plasmodium genus primers. The LAMP result was also in very good agreement (κ = 
0.91) with Giemsa microscopy for Plasmodium parasite detection. For P. falciparum primers, 
LAMP assay showed sensitivity and specificity of 100% and 81.16%, respectively with 
moderate agreement (κ = 0.577) for diagnosis of P. falciparum parasite. 
Conclusion: - The result of this study signifies that LAMP assay can be used as an 
alternative method for the diagnosis of malaria in control and elimination strategies in 
endemic areas. However, further onsite performance evaluation studies should be done in 
different settings to supplement this finding before implementing LAMP as malaria 
diagnostic method in Ethiopia. 
Keywords: - Malaria, diagnostic accuracy, LAMP, Giemsa Microscopy 
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1. INTRODUCTION  
Malaria is a complex and deadly parasitic disease caused by five species of protozoan 
parasites of the genus Plasmodium that affect human (Plasmodium falciparum 
(P.falciparum), Plasmodium vivax (P.vivax), Plasmodium ovale (P.ovale), Plasmodium 
malariae (P.malariae) and Plasmodium knowlesi (P.knowlesi)). Among five species, P. 
falciparum and P. vivax are the predominant species attributing for the majority of disease 
burden worldwide (1, 2).  
Malaria is leading public health problem that remains one of the most important causes of 
human morbidity and mortality with enormous medical, economic and emotional impact 
in the world especially in sub-Saharan African countries (2, 3). According to 2013 world 
malaria report, there were an estimated 207 million cases and 627,000 deaths due to 
malaria in 2012, of which approximately 90% of all deaths occurred in sub-Saharan 
Africa, and 77% (about 483,000) of deaths occurred in children under five years old (4).  
Ethiopia is one of the victims of malaria in sub-Saharan African countries.  Plasmodium 
vivax and Plasmodium falciparum contributes 40% and 60% of malaria infections 
respectively (5, 6) and recently there has been a major shift from P. falciparum to P. vivax in 
different areas of the country (7). The Federal Ministry of Health (FMOH) estimates that 
there are 5–10 million clinical malaria cases each year. This makes malaria to be placed as 
the first cause of health problem accounting for 12% of outpatient consultations and 10% 
hospital admissions (8). According to the 2009/2010 health and health indicators report, 1581 
malaria deaths were reported in Ethiopia (9). Surprisingly, in the nationwide child survival 
study, malaria affects 20% of school attendants and contributes to 47% of the child deaths in 
Ethiopia (10).  
The Ethiopian government is implementing a five year National Strategic Plan for Malaria 
Control and Prevention since 2011. As a result of this, the strategy outlined prompt treatment 
and management of patient’s with malaria. For this achievement, early and accurate malaria 
diagnosis plays crucial role. Clinical diagnosis and parasitological confirmation are the 
approaches of malaria diagnosis employed throughout the country (11-13). Diagnosing 
malaria using clinical features is simple and inexpressive. However, it has low specificity and 
increases the chances of misdiagnosis of patient. World Health Organization (WHO) 
recommends that malaria case management should be based on parasite based diagnosis in all 
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cases. Treatment only on basis of clinical diagnosis is the last option, when parasitological 
diagnosis methods are not accessible in low resource settings (11, 12). 
Currently there are range of parasitological methods to confirm and diagnose malaria 
including the light microscopy, rapid diagnostic tests (RDTs) and molecular techniques such 
as the polymerase chain reaction (PCR) (12, 13). Microscopy and RDT are the routine 
methods employed for diagnosis of malaria in Ethiopia (11). Although, microscopic 
examination of Giemsa stained blood films is considered the gold standard method for the 
diagnosis of malaria in all health centers and hospitals, it requires experience and intensive 
training on the part of the microscopist and needs careful preparation and application of 
reagents to ensure quality result (14, 15). Rapid diagnostic tests are used as alternative 
methods for the diagnosis of malaria in all health facilities. These methods are relatively 
easier to perform and used for screening of malaria in remote areas where electricity and 
other resource are limited. However, the method reveals inconsistency of performance 
(Sensitivity 20% to 99%) and stability problem in rural health facilities (recommended 
storage temperature <30°C) (13-15).    
Recently, nucleic acid based molecular malaria diagnostic tests are developing as a point of 
care (POC) because they can detect species and quantify low-level infections as compared to 
microscope and RDT (16). Polymerase chain reaction (PCR) is very sensitive and specific 
which can effectively detect low-level infections missed by either RDTs or microscopy, and 
has a limit of detection of 0.5–5 parasites/µl.  However, the method is prone to contamination 
and reagents must be stored in cold conditions to maintain their function. The technique is 
also laborious and requires high technical experience. Therefore, PCR assays are the less 
feasible to be used as POC for malaria diagnosis (16, 17). 
The novel molecular diagnostic method has been developed in 2000 by Notomi, et al called 
Loop mediated isothermal amplification (LAMP) which can amplify DNA with high 
specificity, efficiency and rapidity under isothermal conditions (60-65oc). The method 
employs DNA polymerase and four or six genus and species-specific primers that recognize a 
total of six or eight distinct gene sequences on target mitochondrial DNA of the parasite. The 
method can amplify DNA/RNA 109-1010 times with high specificity and can detect 
parasitemia as few as five parasites per microliter of blood, which is not detected by 
microscopy and RDT (18, 19). The reactions of LAMP take place in closed system resulting 
less risk of contamination. Results can be read simply by observing florescence or turbidity 
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visually or real time turbedimeter. Moreover, the method is cost effective as no special 
reagents and sophisticated equipment is required, and the assay can be performed in less than 
an hour (18). Fortunately, a study from Uganda indicated that laboratory technicians 
performed the LAMP assay with short training period and delivers every result within 15 
minutes (20). Therefore, LAMP can be the new and feasible molecular POC technology 
suggested for diagnosis and screening a population in elimination campaigns of malaria (16, 
21, 22). In Ethiopia, the diagnostic performance of LAMP for malaria diagnosis is not yet 
known and should be evaluated to implement as malaria diagnostic method throughout the 
country. 
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2. LITERATURE REVIEW  
Studies were conducted in different parts of the world to determine the performance of 
LAMP against current malaria diagnostic methods such as microscope, RDT and PCR.  Most 
of the studies verified very good diagnostic performance of LAMP kit for diagnosing malaria 
compared to common reference methods, microscopy and PCR (23-30). 
A study was conducted in Sao Tome, Taiwan to compare the performance of four malaria 
diagnostic methods (RDT, microscope, nested PCR and LAMP). The result revealed that 
LAMP method had sensitivity, specificity, positive predictive value (PPV) and negative 
predictive value (NPV) of 98%, 77, 71 and 98%, respectively using microscopy as Gold 
standard. The result of LAMP assay was also in good agreement (Kappa=0.84) with Giemsa 
microscopy (23). In Western Thailand LAMP method showed the sensitivity of 98.5% and 
specificity of 94.3% by using microscopy as reference method. The LAMP assay detected 
three positives from previously microscopically negative samples (24).  
At field clinics in Thailand LAMP method was evaluated for the diagnosis of malaria 
compared with reference method microscopy. Among 110 blood samples collected, LAMP 
showed sensitivity, specificity, NPV and PPV of 98.3%, 100%, 98% and 100%, respectively 
(25). Another LAMP study in field clinic of Thailand showed sensitivity, specificity, PPV, 
and NPV of 95.7%, 100%, 100%, and 98%, respectively, using microscopy as gold standard 
from 219 patients. Similarly by using 680 patients samples LAMP demonstrated sensitivity, 
specificity, PPV and NPV of LAMP were 88.9%, 96.9%, 92.2%, 95.5%, respectively (26). 
Studies revealed that LAMP had comparable diagnostic performances with microscopy for 
the diagnosis of P.faliciparum. Study in Japan demonstrated 97.8% sensitivity and 85.7% 
specificity using microscopic method as reference (27). In Bangladesh, for diagnosis of 
symptomatic falciparum malaria, LAMP assay showed sensitivity and specificity of 99.1% 
and 99% respectively, compared to microscopy. The results of LAMP method also 
demonstrated very good agreements (k=0.94) with results of microscopy (28). 
Evaluation studies demonstrated consistently high diagnostic accuracy of LAMP in 
diagnosing vivax malaria by using microscopy as reference method. In central China, LAMP 
detected vivax malaria parasites in 160 of 164 microscopically positive samples (sensitivity, 
97.6%) with no false-positive results (specificity, 100%) (29). Similarly in Republic of 
Korea, LAMP detected vivax malaria parasites in 115 of 117 microscopically positive 
samples (sensitivity, 98.3%), and detected no positives from 30 microscopy negative patients 
(specificity, 100%) (30).  
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3. SIGNIFICANCE OF THE STUDY 
In Ethiopia, routine malaria diagnostic methods are less sensitive to detect low level of 
parasitemia. Microscopy requires a high level of personnel skills and it is not applicable in 
low resource settings. RDTs have variable performances and require low temperature storage 
conditions in hot rural areas. However, for better and sustainable control of malaria, 
availability of more rapid, easy, sensitive and specific method of diagnosis is crucial. A 
simplified molecular diagnostic test which is rapid, sensitive, specific, easy to use and low 
cost nucleic acid amplification test called LAMP was developed as point of care for malaria 
diagnosis. The diagnostic performance of this novel molecular method was not evaluated and 
implemented as a normal laboratory diagnosis tool in Ethiopia. Hence, this study was aimed 
to evaluate performance of LAMP with microscopy for the diagnosis of malaria at Kola Diba 
Health Center, Northwest Ethiopia. The study provided evidences of diagnostic performance 
of LAMP kit before implementing as malaria diagnostic method in Ethiopia. The study also 
used to strength accurate and early diagnosis of malaria for administering appropriate and 
effective treatments outlined in National Strategic Plan for Malaria Control and Prevention.  
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4. OBJECTIVES  
4.1.General objective 
• To compare the performance of loop mediated isothermal amplification with Giemsa 
microscopy for the diagnosis of malaria in Kola Diba Health Center. 
4.2.Specific objectives  
• To compare the diagnostic accuracy (sensitivity, specificity Positive/Negative 
predictive value) of LAMP with Giemsa microscopy for the diagnosis of malaria 
• To determine the agreement (Kappa value) between LAMP and microscopy to measure 
consistency of results in the diagnosis of malaria 
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5. MATERIALS AND METHODS 
5.1. Study area 
The study was conducted at Kola Diba Health Center, Northwest Ethiopia. The health center 
is found in Dembia District, North Gondar administrative zone in Amhara region. Kola Diba 
is located 35 km far from Gondar town and 729 km North of Addis Ababa. Dembia district is 
known for its flat land and covers an area of 1270 km with altitude ranges between 1750 and 
2100m above sea level. The estimated total population of the district is about 263000; 
majority of the population depends on subsistence farming (31). Dembia district is malarious 
and lies close to Lake Tana. Malaria is the most prevalent seasonal disease in the area, 
accounted as second of all the reported diseases in the health center and October to December 
is the peak malaria transmission season in the area. Plasmodium vivax, Plasmodium 
falciparum and Plasmodium ovale are the parasite species that exist in the area (32, 33).  
5.2.Study design and period 
A cross sectional study was conducted to compare the performance of LAMP with Giemsa 
microscopy for the diagnosis of malaria from March 2014 to May 2014 at Kola Diba Health 
Center, Northwest Ethiopia 
5.3.Population  
5.3.1. Source population 
All clients seeking medical intervention for malaria in the health center  
5.3.2.  Study population 
All febrile patients suspected for malaria during clinical examination in the out patients’ 
department of Kola Diba Health Center during the study period  
5.4.Sample size and Sampling technique  
Study participants were recruited consecutively from malaria suspected febrile outpatients 
referred to the laboratory for malaria testing. Sample collection and microscopic examination 
was done for 200 study participants who attended the health center during study period.  
Among them, only eighty two malaria suspected participants (thirty microscopically positive 
and fifty two systematically selected microscopically negative participants) were included in 
LAMP diagnostic accuracy study. 
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5.5.Study variables 
5.5.1. Dependent variable 
Sensitivity, specificity, predicative and kappa value of LAMP 
5.5.2. Independent variables 
Age, sex, parasite density, plasmodium species 
5.6.Inclusion criteria  
Fibril outpatients suspected for malaria based on the physical examination was included.  
5.7. Exclusion criteria  
Patients who had received anti-malarial drugs during the past four weeks and critically ill 
patients who were unable to give blood sample were excluded from participation.  
5.8.Data collection  
Demographic and clinical characteristics of the study participants were recorded in to data 
collection sheet.  
5.9.Sample collection, laboratory methods and procedures   
Blood collection and microscopic diagnosis of malaria  
Capillary blood was taken from consequently recruited 200 study participants, and both thick 
and thin blood film was done for microscopic detection of plasmodium parasites. Properly 
made thin and thick blood film was stained with 10% Geimsa solution for 10 min and 
examined by experienced and trained laboratory personnel according to diagnostic protocols. 
The presence of malaria infection was ruled out after examining at least 100 microscopic 
fields with 100X objective. The parasitemia was estimated by counting the number of 
parasites per 200 white blood cells in a thick blood film and then calculated the parasite count  
per microliter by assuming the total white blood cell count of 8,000/µl  (34). 
Blood collection and malaria LAMP Assay 
About four milliliter of venous blood was drawn from eighty two microscopically confirmed 
study participant and dispensed in to EDTA tube. The EDTA blood was stored at 2-8ᵒC in 
Kola Diba health center for four days. Weekly on Friday the collected sample was 
transported to University of Gondar laboratory using an ice Bag and stored at -80oC until 
processed by LAMP kits. After two months of collection, the LAMP assay was started.  
The LAMP assay used in this study was based on detection of parasite mitochondrial DNA. 
Malaria Pan/Pf LAMP kits consisted of plastic reaction tubes containing thermostable 
vacuum-dried reagents (LoopampTM Malaria Pan/Pf detection kits, Eiken Chemicals, Tokyo, 
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Japan) were used to amplify Plasmodium/ P. falciparum DNA. The parasite DNA was 
extracted by Boil and spin method. The NINA H.V6 prototype heater device was used to 
produce isothermal conditions suitable for amplification of DNA (63-65OC). The LAMP 
reaction produces turbidity which was detected visually as result of large quantity of 
insoluble magnesium orthophosphate, byproduct of DNA amplification. Sample processing 
and result interpretation with LAMP was done based on protocols stated under Foundation 
for Innovative New Diagnostics 2012 (Eiken Chemicals, Tokyo, Japan) (35). 
Quality control  
Questionnaire for socio-demographic and clinical characteristics was developed in English 
and translated to Amharic language then translated backs to English to check its consistency. 
Socio- demographic data was filled to pre-sated data collection format. All materials and 
reagents for the Giemsa microscopy and LAMP were used as per manufacturer’s instruction. 
Laboratory personnel performing the two test procedures (Giemsa microscopy, LAMP kit) 
were blinded to any result of other test during the course of the study. Giemsa microscopy 
was performed by two experienced laboratory personnel’s and reliability of the results was 
checked blindly by the third expert and this reading was taken as it is, if any discordant was 
existed between the two readers. The parasite density was the average of the two laboratory 
personnel’s parasite count. If more than 10% discrepancy observed between the two readers 
parasite count, the third expert blindly counted parasite load and the result was taken as it is.  
The LAMP assay was done by one laboratory technologist after obtaining 3 day training in 
the test procedure. Three separate rooms were use to perform DNA extraction, mixing of 
reagents and sample, and amplification respectively. All the sample processing’s were done 
in one way. The sample test result was read and interpreted by observing turbidity after 
LAMP reaction using positive and negative control results as comparator. Two other 
laboratory technicians were blindly read and record turbidity observed in the LAMP reaction, 
and records of the two readers having the same result were regarded as correct result of 
LAMP assay.  
Collected data was checked for completeness and entered into computer Microsoft Excel 
program in double entry system to assure consistency of the data.  
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5.10. Operational definitions  
 Diagnostic accuracy:- The amount of agreement between the results from the index test and 
those from the reference standard which can be expressed in sensitivity ,specificity, 
predictive value, kappa value, etc. 
Gold standard method: - refers to a diagnostic test or benchmark that is the best available 
under reasonable conditions. It does not have to be necessarily the best possible test for the 
condition in absolute terms. 
Negative predictive value:-The probability that a negative result accurately indicates the 
absence of infection. 
Positive predictive value: - The probability that a positive result accurately indicates the 
presence of infection. 
Point of care test:-tests designed to be used at or near the site where the patient is located, 
that do not require permanent dedicated space, and that are performed outside the physical 
facilities of the clinical laboratories.  
Sensitivity: - The probability that patients with the infection (determined by the result of the 
reference test will have a positive result using the test under evaluation. 
Specificity:-The probability that patients without the infection (determined by the result of 
the reference test) will have a negative result using the test under evaluation 
5.11. Data analysis and interpretation 
After assuring data completeness, data was entered into computer Microsoft Excel program, 
transferred and analyzed by SPSS version 20 and MedCalc online software for diagnostic test 
evaluation. Sensitivity, specificity, and positive and negative predictive values was 
determined and compared using Giemsa microscopy as gold standard for diagnosis of 
malaria.  Kappa value was determined to check method agreements between LAMP and 
Giemsa microscopy.  
5.12. Ethical consideration  
The study protocol was reviewed and approved by Research and Ethical Review Committee 
of School of Biomedical and Laboratory Sciences, College of Medicine and Health Sciences, 
University of Gondar. Permission to conduct the study was obtained from Dembia district 
health beaurue. Written informed consent and assent form was also taken from every study 
participant, adults/guardians and children, respectively.  Patients found to be positive for 
malaria infection were treated according to the current malaria treatment guideline for 
malaria in the country. 
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6. RESULTS 
Characteristics of the study participants 
A total of 82 study participants were enrolled in this study. Of the 82 study participants, 52 
(63.4%) of them were males. Fifty percent of study participants were between the age of 18 
and 35 years old with median age of 25 years (Md=25, IQR=18-35). All study participants 
were reported history of fever in the past 24 hours.  
Giemsa microscopic results on malaria diagnosis 
From the total of 200 patients diagnosed for malaria using Giemsa microscopy, 30(15%) 
were confirmed positive for Plasmodium parasites with a median parasite density of 9800 
parasites/µL (parasitemia range =420–186,800 parasites/µL). Of those positives, 13 (43.3 %) 
patients had P. falciparum infection (parasitemia = 480–186,800 parasites/uL) and 17 
(56.7%) patients had P. vivax infection (parasitemia= 420-54,000 parasite/ul). Mixed 
plasmodium parasite infection was not identified by Giemsa microscopy during the study 
period.  
Results of LAMP Assay on the diagnosis of malaria  
Among 82 study participants diagnosed by LAMP assay using LoopampTM Malaria Pan 
Detection kits, 38 (46.3%) of them were identified as positive for Plasmodium (Table 1). Of 
those positive study participants, 26 (68.4%) of them were tested positive for P. falicparum 
and the remaining 12 (31.6%) were negative for P.faliciparum using LoopampTM Malaria Pf 
detection kits. 
Table 1.  LAMP result compared with Giemsa microscopy result for 82 patients 
diagnosed by both tests for plasmodium parasite detection in Kola Diba health center, 
Northwest Ethiopia, 2014 
Test and result 
 
             Giemsa  Microscopy                                              
 Positive                          Negative                            Total 
LAMP            Positive 
                        Negative 
 30                                     8                                          38 
   0                                     44                                         44 
Total  30                                     52                                         82 
LAMP- Loop mediated isothermal amplification. 
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Diagnostic accuracy of LAMP method compared with Giemsa microscopy for diagnosis 
of malaria  
The LAMP showed good diagnostic performances for the diagnosis of malaria while using 
Giemsa microscopy as reference method. Compared with Giemsa microscopy, LAMP assay 
had sensitivity and specificity of 100% (95% CI: 88.32 % to 100%) and 84.62% (95% 
CI: 71.91% to 93.10%), respectively. The positive and negative predictive values of LAMP 
for detecting plasmodium parasites were 78.95% (95% CI: 62.67% to 90.42%) and 100% 
(95% CI: 91.88% to 100%), respectively. The LAMP result had also very good agreement (κ 
= 0.91) with Giemsa microscopy for detection of Plasmodium parasites (Table 2).  
For the detection of P. faliciparum, the sensitivity and specificity of LAMP was 100% (95% 
CI: 75.12 % to 100) and 81.16 % (95% CI: 69.94 % to 89.56 %), respectively. The 
corresponding positive and negative predictive values were 50% (95% CI: 29.94 % to 70.06 
%) and 100% (95% CI: 93.56 % to 100%), respectively. In this study, Giemsa microscopy 
and LAMP assay showed moderate agreement (κ = 0.577) for identification of P. falicparum 
parasite (Table 2). 
Table 2:- Diagnostic accuracy of LAMP compared with the reference Giemsa 
microscopy method for diagnosis of plasmodium parasite and P.faliciparum at Kola 
Diba health center, Northwest Ethiopia, 2014 
Comparison, 
Primer Set 
Senstivity(%) 
95% CI                        
Specificity(%) 
95% CI 
PPV(%) 
95% CI 
 
NPV(%) 
95% CI 
Kappa 
Value  
 
Pan-Plasmodium 
genus 
 100 
88.32-100 
84.62 
71.91-93.10 
78.95 
62.67-90.42 
100% 
91.88 -100 
0.91 
P.faliciparum  100 
75.12- 100 
81.16 
69.94 -89.56 
50% 
29.94-70.06 
100 
93.56-100 
 0.57 
 NPV = negative predictive value; PPV = positive predictive value; P. falciparum=Plasmodium falciparum 
Kappa value =the percentage agreement between results of LAMP and Giemsa microscopy (> 0.8, almost 
perfect agreement; 0.61-0.8, substantial agreement; 0.41-0.6, moderate agreement; 0.21-0.4, fair agreement) 
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7. DISCUSSION  
Malaria is being the leading cause of public health problem throughout the world. Sub-
Saharan African countries account the highest burden of malarial mortality and morbidity (2-
4). Early and accurate diagnosis of malaria in every health service facility is required for 
prompt treatment and case management of malaria (10-12). Recently nucleic acid based 
molecular diagnostic kit known as LAMP was developed and evaluated for diagnosis of 
malaria in different parts of the world. Studies suggested that this molecular diagnostic kit 
would be used as point of care for diagnosis of malaria (16, 21). Compared with other malaria 
diagnostic methods, the diagnostic accuracy (sensitivity and specificity) of LAMP varied in 
different studies.  
The current LAMP kit evaluation study demonstrated good diagnostic accuracy for the 
diagnosis of malaria as compared with Geimsa microscopy which satisfies the WHO 
recommendations that requires diagnostic kits sensitivity of greater than 95%. For the 
detection of Plasmodium parasites, LAMP assay showed sensitivity of 100% which indicates 
that the kit is highly sensitive and can be used for diagnosing patients suspected of malaria. 
Compared to other LAMP evaluation studies conducted in similar settings, this study 
revealed relatively higher sensitivity. Study in western Thailand showed 98.5% sensitivity 
when compared with Giemsa microscopy (24). Furthermore, studies conducted at filed clinics 
in Thailand on LAMP assay demonstrated sensitivity of  98.3%, 95.7% and 88.9% while  
using 110, 219 and 680 blood samples, respectively as compared Giemsa microscopy(25, 
26).The difference of sensitivities might be attributed due to use of small sample size in the 
current study (n=82). 
Compared to other diagnostic accuracy studies, the specificity of LAMP in the present study 
is somewhat lower. Using Giemsa microscopy as gold standard method, study conducted in 
Western Thailand’s showed specificity of 94.3% (24). At field clinics of Thailand, LAMP 
assay was done three times by using different sample sizes and demonstrated specificity of 
greater than 95% (25, 26). Moreover, recent LAMP assay in Japan showed almost similar 
specificity (85.7%) with the present study using microscopic methods as reference (27). In 
this study, LAMP detected eight samples as malaria positive which were confirmed as 
negative by Giemsa microscopy. This discrepancy might be linked with the difference in 
detection limit of the two methods. Giemsa microscopy couldn’t detect parasite densities 
below 100 parasites/µl of blood (36). In contrast, LAMP method has the ability to detect 
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plasmodium parasitemia as few as five parasites per microliter of blood (19). Therefore, since 
the present study was conducted in malaria endemic area, the eight positive results obtained 
by LAMP might be due to parasite density below the detection threshold for microscopy but 
detectable level by LAMP assay. Recent study in Northwest Ethiopia also revealed that 
nested PCR was detected 13.1 % (39/297) positives which had been confirmed negative by 
Giemsa microscopy. These high level discordant result was associated with the skills and 
experiences of microscopists to detect and identify plasmodium parasites,which may affect 
the LAMP evaluation study(37).  
The present study demonstrated that LAMP assay has high ability of predicting the true 
negatives (NPV, 100%) than true positives (PPV, 78.95%) for detecting plasmodium 
parasites. Studies conducted at field clinics of Thailand using 110 and 680 malaria suspected 
patients showed LAMP‘s high ability of predicting both true negatives and true positives 
(NPV and PPV of 98%, 95.5%, and 100%, 92.2%, respectively) (25, 26). This study dictated 
that all patients not having malaria by LAMP method were previously confirmed negatives 
with reference microscopy. Since, LAMP assay has high efficiency of amplification and 
detection of parasite DNA, the probability that LAMP assay missing positives by microscopy 
was almost zero (18).  
The current LAMP assay was done using pan–Plasmodium genus primers and P. falciparum 
primers. Using LoopampTM malara Pf kits containing P. falciparum primers, 13 samples were 
identified as P. falciparum positive which were not classified as P. faliciparum in 
microscopic examinations. Positives for LoopampTM Malaria Pf detection kits may be either 
monoinfection with P.falicparum or mixed infections with P.falicparum and other 
plasmodium species. For diagnosis of symptomatic falciparum malaria, this LAMP study 
demonstrated lower specificity (81.16%) using microscopy as reference method. The possible 
reason might be high rate of misclassification and identification of plasmodium parasite 
species using Giemsa Microscopy in the study area. Recent comparative evaluation study 
detected 4.7% (14/297) mixed infections by nested PCR which were not identified any mixed 
infections by Giemsa microscopy in Northwest Ethiopia (33, 37). 
In general, in this study LAMP method was highly sensitive test for diagnosis of malaria. 
Such tests are more appropriate for diagnosis of acute, fatal and treatable diseases like 
malaria. In addition to good diagnostic performance of LAMP, the test procedure was done 
with short term trainings without previous experiences, and reading of test result was 
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objective which didn’t require individual subjective judgments compared to Giemsa 
microscopy. Negative and positive controls were used for interpretation of sample test results. 
For running one batch containing four samples, the whole test procedure took 45-60 minutes. 
The LAMP test procedure used in this study did not require special equipments and can be 
used in remote malaria endemic areas. Therefore, this test can be the first molecular rapid 
diagnostic method that would be used as point of care for the diagnosis of malaria. 
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8. CONCLUSION  
This LAMP test evaluation showed good diagnostic accuracy as compared to the reference 
Giemsa microscopy for diagnosis of malaria suspected febrile patients in Ethiopia. The 
LAMP method was highly sensitive for detection plasmodium parasites. The method was 
simple and experience was not required to perform the test procedure. The result of the test 
was also easy to read and interpret as compared to Giemsa microscopy. Thus, the LAMP kit 
can be the potential alternative and promising diagnostic method to replace Giemsa 
microscopy for accurate diagnosis of malaria in supporting malaria prevention and control 
programs at endemic areas.  
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9. LIMITATIONS OF THE STUDY  
Even though, this LAMP evaluation study revealed good diagnostic performances as 
compared to Giemsa microscopy, it had its own limitations. The first limitation of this study 
was use of relatively small sample size due to the availability of limited LoopampTM Malaria 
Pan/Pf detection kits. The other weakness of the study was use of microscopy as reference 
test method which is an imperfect gold standard, especially in low parasitaemia conditions. 
The third limitation was the absence of real time turbidimetry instrument which could 
provide threshold of amplified DNA product with time.   
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10.  RECOMMENDATIONS 
The finding of this study recommends and suggests for:- 
A. Researchers  
• Further onsite performance evaluation studies to validate the diagnostic accuracy of 
LAMP in different settings, particularly in remote health centers and clinics. 
Evaluations should be done using highly sensitive, specific and perfect gold standard 
malaria diagnostic methods such as nested PCR.  Evaluation studies with high sample 
size should also be done to verify the reliability of this finding. 
B. Government  
• The Ethiopian federal ministry of health and minister’s of science and technology 
should give emphasis on the evaluation of this new innovative diagnostics for malaria 
in malaria endemic and low transmission areas of the country. 
• Governmental malaria control offices should organize LAMP method protocol for 
standardized evaluation and possible implementation as part of diagnostics for malaria 
in the future  
C. Nongovernmental organizations working on malaria control and prevention should 
collaborate with LAMP evaluation projects for diagnosis of malaria by incorporating 
LAMP evaluation as part of their implementation plan.  
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12. ANNEXES 
I. Participant Information sheet 
 
UNIVERSITY OF GONDAR 
COLLEGE OF MEDICINE AND HEALTH SCIENCES 
Introduction 
My name is Meslo Sema from University of Gondar, College of medicine and health 
sciences. I am doing my MSc research on the evaluation of the diagnostic performance of 
new diagnostic method called LAMP for diagnosis of malaria at Kola Diba Health Center, 
North west Ethiopia. The purpose of this study is to confirm the ability of LAMP for the 
diagnosis of malaria. 
So you are invited to participate in this study. Please read the following statements and ask 
any unclear points before you agree to participate. 
Your participation in this study is entirely voluntary. If you choose not to consent, all the 
services you receive at this clinic will continue as usual. Even if you agree now but decide to 
change your mind and withdraw later, the services you receive at the clinic will continue. If 
you decide to participate, you have to sign on the consent or assent template form and you 
may obtain a copy of this information sheet.  
What is expected from me as participant of the study? 
As a participant of this study, you are expected to agree that about 3 ml blood will be taken 
from your arm. In addition, you are expected to give answers for some questions about your 
socio-demographic conditions.  
How much time will I spent to participate in this study? 
You will spend 30-45 minutes until the blood specimen is collected, the consent /assent 
permission form is signed. 
What are the risks of participating in this study? 
You may experience a bit of pain or fear when your arm is punctured during specimen 
collection. But, the pain disappears within few hours.  
How my information is to be kept in secrete? 
All information that you give and the results from your specimen will be used for this study 
only. Nothing else will be done with your blood other than the study. We will not share the 
identity of participants in the study with anyone. The information that we collect from this 
study will be kept confidential. Any information collected about you will have a number on it 
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instead of your name. Only the study team members will know what your number is and we 
will lock that information up. . 
What are the benefits from participation? 
Since this study is MSc student research, there will not be payments for participants. But your 
participation will help us to make sure ability of LAMP for the diagnosis of malaria and this 
will benefit society and future generations.  
What are my rights as a participant of this study? 
You have the right to withdraw yourself from the study at any time and all the services 
provided in the Health center will not be discontinued. You are also welcomed if you have 
any question for further explanations about the study. You can get the results of the analysis. 
What can I do if I have a problem or a question? 
Please direct any questions or problems you may encounter during this study to: 
Meslo Sema  
Department of Medical parasitology, College of medicine and Health Sciences 
University of Gondar  
Mob: +251910463319 
Email: mesem2000@gmail.com 
Agree to participate?                    Yes         No 
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II.  Consent/assent Form 
This page contains an agreement signature to participate in the study entitled with “Evaluation of 
Loop Mediated Isothermal Amplification kit with Giemsa microscopy for the diagnosis of 
malaria in northwest Ethiopia”. So please read the following points and sign your signature at the 
end in the space provided.  
Consent form for adults 
1. I understand the objective of the study in “Evaluation of Loop Mediated Isothermal 
Amplification kit with Giemsa microscopy for the diagnosis of malaria in northwest Ethiopia” 
and I can communicate with the peoples that conduct the study when I want them. 
2. I know that the information that I gave are going to be used for this study only.  
3. I understand that, all the information given for the study and the results are confidential.  
4. I understand that I will not get any money for my participation.  
5. I understand that I have a right to stop from participation any time in the study.  
6. All the information is explained by Mr. /Mrs____________________ 
7. I agree to participate in this study  
Name of the participant ______________ 
Signature of the participant: __________________  
Date: _________________ 
Assent form for children and young  
I understand the objective of the study in “Evaluation of Loop Mediated Isothermal 
Amplification kit with Giemsa microscopy for the diagnosis of malaria in northwest Ethiopia” 
and I can communicate with the peoples that conduct the study when I want them. 
2. I know that the information that I gave are going to be used for this study only.  
3. I understand that, all the information given for the study and the results are confidential.  
4. I understand that I will not get any money for my participation.  
5. I understand that I have a right to stop from participation any time in the study.  
6. All the information is explained by Mr. /Mrs____________________ 
7. I agree my child to take part in the study   
Parent /gardian Name ______________ 
Signature of the participant: __________________  
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Date: _________________ 
.or   
Child’s signature (only if the child assents):  
Print name of child: ___________________ 
Signature of child: ___________________ 
Date:                     ___________________ 
Please direct any questions or problems you may encounter during this study to: 
Please direct any questions or problems you may encounter during this study to: 
Meslo Sema  
Department of Medical parasitology, College of medicine and Health Sciences 
University of Gondar  
Mob: +251910463319 
Email: mesem2000@gmail.com 
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}[É‰KG<::  
 Ÿ²=I Ø“ƒ Ñ”²w u}K¾ SMŸ< ›”ÅTLÑ˜ }`É‰KG<::  
Ÿ²=I Ø“ƒ uðKÓG< Ñ>²? ›k`Þ S¬×ƒ ›”ÅU‹M }[É‰KG<::  
ÃI S[Í u›„/ ¨/a }ÑMïM—M:: 
 uØ“~ KSd}õ }eTU‰KG<:: 
¾}d}ò cU------------------------------- 
¾}d}ò  ፡ò`T ------------------------   
፡k” ----------------------------  
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¾}dƒö eUU’ƒ pî KIí“ƒ“ K}ÇÑ>−‹ 
1. ¾Ø“~” ¯LT }Ñ”´u›KG ፤  Ø“~” ¾T>ÁŸH@É¬” c¬ eðMÑ¬ TÓ–ƒ 
    ›”ÅU‹MU }[É‰KG<::  
2. ¾ÅU “S<“  }¨eÊ KØ“~ ¯LT  w‰  ›”ÅT>¬M }[É‰KG<::  
3. KØ“~ ¾T>WÖ< S[Í−‹“ ŸØ“~ ¾T>Ñ–< ¬Ö?„‹ uT>eØ`  °”ÅT>Öul 
}[É‰KG<::  
4. Ÿ²=I Ø“ƒ Ñ”²w u}K¾ SMŸ< °”ÅTLÑ˜ }`É‰KG<::  
5. Ÿ²=I Ø“ƒ uðKÓG< Ñ>²? ›k`Þ S¬×ƒ °”ÅU‹M }[É‰KG<::  
6. ÃI S[Í u›„/ ¨/a/}ÑMïM—M::  
7. MË uØ“~ °”Ç=d}õ }eTU‰KG<:: 
¾}d}ò Ií” ¨LÏ ¨ÃU ÁdÇÑ> cU  
¾¨LÏ ¨ÃU ÁdÇÑ ò`T-------------------------- 
፡k”  --------------------------- 
 okxP/ c 7 p( Ni" J'D
 
© 4 okx --------------------------------- 
L------------------------------- 
M------------------------------------- 
i B9XE7 4 *y B2E7
      
               
             N%B" 6K 7/b"!     
              z	 
ሞባ ይ ል  251910463319 
ኢ -ሜይ ል  mesem2000@gmail.com        
 
 
 
 
 
 
 
 
 
29 
 
III. Questionnaire   
Questionnaire on Socio-demographic and clinical characteristics of the respondent 
This questionnaire contains two parts that Socio-demographic and clinical characteristics. For 
each question please give the answer carefully with patience.  Your name is not included in the 
questionnaire. Your answer will not be exposed to anyone. 
Questionnaire no.________ Name of interviewer _______Date__________ 
1. Socio-demographic characteristics   
  ID no. of suspect _____________________   Age ________  
Sex       A. Male         B. Female  
 Address, Zone ___________Woreda __________ Kebele ______________ 
 Residence   A. Urban                B. Rural       
2. Clinical characteristics of the patient  
When you feel ill first? _____________________ 
Have had laboratory confirmed malaria in the previous six months?    A. Yes   B. No     
When? Please specify___________________        
Do you have fever that repeats within 48 hours? A. Yes   B. No 
ስ ለ ራ ስ ዎ ና ስ ለ ህ መም ስ ሜት ዎ መረ ጃ ለ መሰ ብ ሰ ብ የ ተ ዘ ጋ ጀ መጠይ ቅ ቅ ጽ        
መጠይቁ ሁለት ክፍሎች ይኖሩታል፡፡ የመጀመሪያው ስለራስዎ ምላሽ የሚሰጡበት ሲሆን ሁለተኛው ደግሞ ስለህመም 
ምልክትና ስሜትዎ የሚገልጹበት ነዉ፡፡ ለእያንዳንዱ ጥያቄ በጥንቃቄና በታማኝነት ያመኑበትን ይመልሱ፡፡ የእርስዎ ማንነት 
በመጠይቁ ውስጥ አይካተትም፡፡ የሰጡት አስትያየትም የእርስዎ ስለመሆኑ በምንም ሁኔት አይገለጽም፡፡ 
መጠይቅ  ቁጥር ---------------- መጠይቁን የሚያቀርበዉ ሰዉ ስም---------------------------ቀን------------- 
ክፍል አንድ፡  እርስዎን በተመለከተ ጥያቄዎች 
የመለያ ቁጥር------------------------------ዕድሜ------------------------------------ 
ፆታ            ሀ. ወንድ         ለ. ሴት 
አድራሻ       ዞን------------------- ወረዳ-------------------------- ቀበሌ----------------
የመኖሪያ ቦታ         ሀ. ከተማ                 ለ. ገጠር 
ክፍል ሁለት፡ ስለህመም ምልክትና ስሜትዎ በተመለከተ ጥያቄዎች 
የህመም ሰሜት የተሰማዎ መቸ ነዉ_____________________________ 
ባለፈዉ ስድስት ወራት ዉስጥ ወባ በላቦራቶሪ ተመርምረዉ ተገኝቶቦታል    ሀ. አዎ     ለ. የለም 
በየሁለት ቀኑ የሚመላለስ የሰዉነት መተኮሰ አለብዎት                        ሀ. አዎ     ለ. የለም    
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IV. Laboratory Procedures 
I. Capillary blood collection  
Materials  
70 alcohols  
Sterile lancets 
Gauze pad   
1. Rub the site vigorously with cotton or a gauze pad moistened with 70% alcohol 
2. After the skin has dried, make a puncture 2-3mm deep with a sterile lancet 
3. Take the first drop of blood and place to slide for making smear 
4. Stop the blood flow by applying slight pressure at the site preferably with a gauze 
pad 
II. Procedures for Venous blood collection   
Materials 
Gloves 
Gauze pads or cottons,  
Sterile syringe and needle  
Heparinzed tubes  
Tourniquet 
70 % alcohol  
Sharp container 
Procedures for collection of venous blood using syringe method  
1. identify and prepare the right patient  
2. Apply the tourniquet 
3. Prepare the arm by a gauze pad or cotton moistened with 70% alcohol  
4. Insert the needle properly into the vein with the bevel facing up 
5. Draw back the plunger to create suction pressure to collect enough amount of blood for 
the tests 
6. remove the needle from the vein and give cotton and  order the patients to press the 
picture site 
7. Transfer the collected blood to heparinied tube and discard the needle safely. 
III. Materials for making blood film preparation, staining and microscopic 
examination Materials 
Microscope slide                  
Staining jars 
Sterile blood lancet                
Timer 
Methanol                               
Forceps 
Giemsa                                  
Staining rack 
Microscope                            
Alcohol 
Cotton                                    
oil immersion  
Slide box 
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A. Procedure for Preparation of thick blood films 
1. Slides must be clean, free from dirt and grease  
2. Using an applicator stick, apply 2 drops of blood on to a microscope slide from 
collected venous blood in tube.  
3. Spread the blood without excessive stirring to form a smear approximately a cm2, 
through which newspaper print can be red.  
4. This should be approximately 5 red blood cells thick.  
5. Allow to air dry horizontally (without using heat). 
6. Label slides. 
 
B. Procedure for Preparation of thin blood films 
1. The microscope slides must be clean as for thick films otherwise the blood will not 
adhere and the smear was irregular. 
2.  Apply 1 drop of blood to the end of the slide, pace another slide at an angle of 45o 
and bring it towards the drop of blood. 
3.  As soon as it touches it, the blood will disperse along the width of the slide. 
4.   Before it reaches the edges, pull the drop along the length of the slide. 
5. The correct amount of blood in the drop the film will form a good tail before the end 
of the slide. The film here should be 1 RBC thick. Make 2 slides for each test. 
6.  Air dry, Label slides  
C. Staining With Giemsa 
1. Immediately before use we will dilute the Giemsa as required with 10% for 10 min 
2. Thin films must be fixed in absolute methanol for at least 30 seconds(1-2min) 
3. Stain  
4. Wash 
5. Drain & dry vertically/ at an angle. 
D. Microscopic examination of blood films 
1. Focus on the film with the 10x objective. 
2. Examining the film first with 40x objective to select a well stained area 
3. Apply a drop of immersion oil on the slide and switch to the oil-immersion objective.  
4. Examine at least 100 fields with (100X Objective). 
E. Estimation of Parasitemia(parasite numbers/µl of blood )  
1. Select a part of the thick film where the white cells are evenly distributed and the 
parasites are well stained.  
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2. Using the oil immersion objective, systematically count 200 white blood cells 
(WBC), estimating at the same time the numbers of parasites (asexual) in each field 
covered. Counting is best done by using two hand tally counters. Repeat this in two 
other areas of the film and take an average of the three counts.   
3. Calculate the number of parasites per µl of blood as follows (37) 
            =WBC count X Parasites counted against  200 WBC  
                 200  
      
 
IV. LAMP technique procedure 
LAMP technique involves three methods of DNA etraction including boil and spin 
method,PURE method and commerrcial kites. Boil and spin method is cheap and does not 
require DNA extraction kits. It can be done with waterbath at 95oC and micrcentrifuge for 
spining .We were used boil and spin method of DNA extraction.  
DNA extraction by the Boil and Spin method 
Eqipment: Water bath at 95°C (temperature accurac 
 Vortex (optional) 
Micro-centrifuge (10,000 g) 
  Timer 
Materials: Marking pen 
 Disposable examination gloves (powder free) 
0.5% sodium hypochlorite 
10-µl to 100-µl micropipette with sterile disposable tips 
Extraction Tube: 1.5-ml eppendorf tube with 60µl extraction buffer 
(400 mM NaCl, 40 mM Tris pH 6.5, 0.4% SDS) 
Dilution Tube: 1.5-ml eppendorf tube with 345 µl sterile water  
Procedure 
• Turn on the water bath and verify that the temperature has reached 95°C.  
• Work with double pair of disposable examination gloves (discard outer ones when 
finishing Sample Processing before starting the LAMP amplification steps). 
• Work in a sample preparation area separated from the amplification area. 
• Clean the bench with 0.5% sodium hypochlorite. 
• Place on this clean surface all required materials. 
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• Write the patient name or code on the cap of the Extraction and Dilution tubes. 
• Transfer 60 µl of whole blood to the Extraction Tube using a 60-µl blood transfer device 
for a finger prick or a micropipette for blood in heparin. Repeat this step for every sample 
being sure of using a single Extraction Tube per sample. 
• Mix the sample and the extraction buffer by vortex for 10 seconds or pipetting 10 times 
•  Place the Extraction Tube with the sample in the water bath at 95°C for 5 minutes. 
• Remove the tube from the water bath immediately after the timer sounds. Over-heating 
may degrade DNA which lowers the sensitivity of the test. 
• Centrifuge at 10,000 g for 3 minutes. 
• Transfer 30 µl of clear supernatant to the Dilution Tube (the precipitated haemoglobin 
makes a browny-red pellet at the bottm of the tube). Mix by pipetting 10 times to dilute 
the DNA sample (S). 
• Repeat these steps for every sample being sure of using a single Extraction Tube and a 
single Dilution Tube per sample. If not used immediately, the DNA sample (S) can be 
stored at -20°C. 
LAMP Reagent mixing procedures 
Equipments and Materials  
Biosafety cabinet II 
Marking pen 
Disposable examination gloves (powder free) 
0.5% sodium hypochlorite 
Sterile Scisor  
Microtube rack  
Infectios wase disposal bag 
10-µl to 100-µl micropipette with sterile disposable tips 
LoopampTM MALARIA Pan/Pf detection kit (REF: LMC562 - Eiken Chemical Co.): 
Malaria Pan Reaction tubes with detection reagents and/or 
Malaria Pf reaction tubes with detection reagents 
Pan/Pf Positive Control (PC) 
Pan/Pf Negative Control (NC) 
Procedures: 
- Read the package insert of the LoopampTM MALARIA Pan/Pf detection kit carefully. 
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- Work in an amplification area separated from the sample preparation area. 
- Clean the bench with 0.5% sodium hypochlorite. 
- Discard outer gloves leaving a single glove in each hand. 
- Place on this clean surface all required materials. 
- Remove the required number of Reaction tubes from the aluminium pouch and put 
them in an appropriate rack (one reaction tube per sample, plus one for Positive 
Control (PC) and one for Negative Control (NC)). Pan and Pf reaction tubes can be run 
simultaneously or separately. 
- After removing the necessary Reaction tubes, seal immediately (tightly closed) the 
aluminium pouch with unused tubes. 
- Flick or spin down the tubes with the Positive (PC) and Negative (NC) controls before 
use to collect the content in the bottom of the tube. 
- Write the patient name or code on the respective Reaction tube. 
-  Dispense 30 µl of diluted DNA sample (sample=S) into the Reaction tube and close 
the cap. Repeat this step for all samples to be amplified in the same run. 
- Dispense 30 µl of Negative Control (NC) into a Reaction tube and close the cap. 
- Dispense 30 µl of Positive Control (PC) into a Reaction tube and close the cap. Always 
dispense the Positive Control (PC) into the last tube as a final step. Dispensing earlier 
may cause contamination. 
- Close the Positive Control (PC) tube immediately after dispensing the required volume 
in the Reaction tube. 
- Pick up the Reaction tubes from the rack and turn the tubes upside down. Shake firmly 
so that the DNA solution moves into the inside of the tube cap. 
- Place the Reaction tubes cap-side down on the bench for 2 minutes. This allows the 
DNA solution to dissolve the dried LAMP reagents inside the tube cap. 
- Invert (turn upside down) the reaction tubes 5 times. Shake the tubes with each 
inversion to ensure proper mixing and dissolving of the LAMP reagents. 
- Finally, shake the reaction tubes downwards to collect the solution into the bottom of 
the tubes (or pulse spin in a micro-centrifuge for a few seconds). 
- Immediately place the reaction tubes into the H.V6 lid 1 of NINA H.V6 prototype 
heater device (at 63-65°C) and close the H.V6 2. 
LAMP amplification 
Equipment and Materials 
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NINA H.V6 prototype heater device  
 Materials and parts of device  
DaqPRO 5300 Data Logger 
H.V6 lid1 
H.V6 lid2 
H.V6 thermos  
Saline cartilidege (5ml blow fill seal) 
MgFe Fuel pack 
Instrumented PCR tube (Type Thermocouples) 
Timer 
 Pen 
Disposable examination gloves (powder free) 
0.5% sodium hypochlorite 
Data collection sheet 
Zip-lock plastic bag (for waste disposal) 
Micro tube rack   
Operating Procedure of NINA H.V6 prototype heater device for LAMP amplification  
1. Connect the Daq Pro charger to 110 V power source  
2. Press “On” on the Daq pro instrument –the “main menu” will appear 
3. Press on “Start Lodging” on the menu-  the  In-1- In 4 will appear with  temperature 
records 
4. Check the proper connection of thermocouples to the Daq pro Data logger 
5. Verify that the devices are condition to 22+ /-2 OC by checking instrumented tube 
temperature 
6. Ensure inside of thermos is dry and wiped clean residue 
7. Place MgFe fuel pack in thermos  
8. Place instrumented PCR Tube in H.V6-lid 1 
9. Press H.V lid 2 into lid 1 firmly until it stops 
10. Add saline cartridges to thermos and  immediately screw lid 1 on thermos 
11. The heater is now activated.  Wait for 15 min for device to reach isothermal 
conditions 
12. Remove lid 2 and insert 4 x samples and quickly close lid 2 
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13. The tube will quickly reach amplification temperature (63-65oc) 
14. After 40 min of amplification press” ESC” on Daq Pro to end logging  session 
15. The test is now complete. unscrew lid 1 from thermos  
16. Remove lid 2 and remove sample tube by using tube extractor. take care not to damage 
wire 
17.  Rinse and clean thermos and dispose spent fuel packs  
18. Allow minimum of 80 min in between tests for the device to cool sufficiently to room 
temperature 
Detection and interpretation of results 
We observed visually any increase in turbidity in the samples and controls. If the turbidity 
increases in the Positive Control but does not in the Negative Control, amplification reaction 
is proceeding properly. If that is not the case, amplification reaction may be proceeding in a 
wrong way. In such a case, restart testing from transfer of DNA solution to reaction tubes 
After confirming that controls are properly working, evaluate samples in accordance with the 
following criteria: 
- Positive Sample: Some increase is observed in turbidity. 
-  Negative Sample: No increase is observed in turbidity. 
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